Literature DB >> 23523700

Constrained selected reaction monitoring: quantification of selected post-translational modifications and protein isoforms.

Xiaoqian Liu1, Zhicheng Jin, Richard O'Brien, Joan Bathon, Harry C Dietz, Eric Grote, Jennifer E Van Eyk.   

Abstract

Selected reaction monitoring (SRM) is a mass spectrometry method that can target signature peptides to provide for the detection and quantitation of specific proteins in complex biological samples. When quantifying a protein, multiple peptides are generated using a specific protease such as trypsin, thereby allowing a choice of signature peptides with robust signals. In contrast, signature peptide selection can be constrained when the goal is to monitor a specific post-translational modification (PTM) or protein isoform, as the signature peptide must include the amino acid residue(s) of PTM attachment or sequence variation. This can force the selection of a signature peptide with a weak SRM response or one that is confounded by high background. In this article, we discuss steps that can be optimized to maximize peptide selection and assay performance of constrained SRM assays, including tuning instrument parameters, fragmenting product ions, using a different protease, and enriching the sample. Examples are provided for phosphorylated or citrullinated peptides and protein isoforms.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523700      PMCID: PMC3990191          DOI: 10.1016/j.ymeth.2013.03.006

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  25 in total

1.  Mechanistic studies of the dual phosphorylation of mitogen-activated protein kinase.

Authors:  J E Ferrell; R R Bhatt
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure.

Authors:  Jiang Zhang; Moltu J Guy; Holly S Norman; Yi-Chen Chen; Qingge Xu; Xintong Dong; Huseyin Guner; Sijian Wang; Takushi Kohmoto; Ken H Young; Richard L Moss; Ying Ge
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

3.  Proteomics: from hypothesis to quantitative assay on a single platform. Guidelines for developing MRM assays using ion trap mass spectrometers.

Authors:  Bomie Han; Richard E Higgs
Journal:  Brief Funct Genomic Proteomic       Date:  2008-06-25

4.  Development of a LC-ESI-MS3 method for determination of nitrendipine in human plasma.

Authors:  Xiaowei Shi; Man Liu; Mengmeng Sun; Qiao Wang; Weina Liu; Deying Cao
Journal:  J Pharm Biomed Anal       Date:  2011-08-16       Impact factor: 3.935

5.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Authors:  Terri A Addona; Susan E Abbatiello; Birgit Schilling; Steven J Skates; D R Mani; David M Bunk; Clifford H Spiegelman; Lisa J Zimmerman; Amy-Joan L Ham; Hasmik Keshishian; Steven C Hall; Simon Allen; Ronald K Blackman; Christoph H Borchers; Charles Buck; Helene L Cardasis; Michael P Cusack; Nathan G Dodder; Bradford W Gibson; Jason M Held; Tara Hiltke; Angela Jackson; Eric B Johansen; Christopher R Kinsinger; Jing Li; Mehdi Mesri; Thomas A Neubert; Richard K Niles; Trenton C Pulsipher; David Ransohoff; Henry Rodriguez; Paul A Rudnick; Derek Smith; David L Tabb; Tony J Tegeler; Asokan M Variyath; Lorenzo J Vega-Montoto; Asa Wahlander; Sofia Waldemarson; Mu Wang; Jeffrey R Whiteaker; Lei Zhao; N Leigh Anderson; Susan J Fisher; Daniel C Liebler; Amanda G Paulovich; Fred E Regnier; Paul Tempst; Steven A Carr
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

6.  Multiple reaction monitoring to identify site-specific troponin I phosphorylated residues in the failing human heart.

Authors:  Pingbo Zhang; Jonathan A Kirk; Weihua Ji; Cristobal G dos Remedios; David A Kass; Jennifer E Van Eyk; Anne M Murphy
Journal:  Circulation       Date:  2012-09-12       Impact factor: 29.690

Review 7.  A tale of two citrullines--structural and functional aspects of myelin basic protein deimination in health and disease.

Authors:  George Harauz; Abdiwahab A Musse
Journal:  Neurochem Res       Date:  2006-08-09       Impact factor: 3.996

Review 8.  Targeted proteomic strategy for clinical biomarker discovery.

Authors:  Ralph Schiess; Bernd Wollscheid; Ruedi Aebersold
Journal:  Mol Oncol       Date:  2008-12-11       Impact factor: 6.603

9.  Neutral loss of isocyanic acid in peptide CID spectra: a novel diagnostic marker for mass spectrometric identification of protein citrullination.

Authors:  Gang Hao; Danchen Wang; Jane Gu; Qiuying Shen; Steven S Gross; Yanming Wang
Journal:  J Am Soc Mass Spectrom       Date:  2008-12-30       Impact factor: 3.109

Review 10.  ERK1/2 MAP kinases: structure, function, and regulation.

Authors:  Robert Roskoski
Journal:  Pharmacol Res       Date:  2012-04-27       Impact factor: 7.658

View more
  11 in total

1.  Selective chemoprecipitation to enrich nitropeptides from complex proteomes for mass-spectrometric analysis.

Authors:  Laszlo Prokai; Jia Guo; Katalin Prokai-Tatrai
Journal:  Nat Protoc       Date:  2014-03-20       Impact factor: 13.491

2.  Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry Enables Multiplex, Quantitative Pharmacodynamic Studies of Phospho-Signaling.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Ping Yan; Richard G Ivey; Uliana J Voytovich; Heather D Moore; Chenwei Lin; Amanda G Paulovich
Journal:  Mol Cell Proteomics       Date:  2015-05-18       Impact factor: 5.911

3.  Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.

Authors:  Andrew N Hoofnagle; Jeffrey R Whiteaker; Steven A Carr; Eric Kuhn; Tao Liu; Sam A Massoni; Stefani N Thomas; R Reid Townsend; Lisa J Zimmerman; Emily Boja; Jing Chen; Daniel L Crimmins; Sherri R Davies; Yuqian Gao; Tara R Hiltke; Karen A Ketchum; Christopher R Kinsinger; Mehdi Mesri; Matthew R Meyer; Wei-Jun Qian; Regine M Schoenherr; Mitchell G Scott; Tujin Shi; Gordon R Whiteley; John A Wrobel; Chaochao Wu; Brad L Ackermann; Ruedi Aebersold; David R Barnidge; David M Bunk; Nigel Clarke; Jordan B Fishman; Russ P Grant; Ulrike Kusebauch; Mark M Kushnir; Mark S Lowenthal; Robert L Moritz; Hendrik Neubert; Scott D Patterson; Alan L Rockwood; John Rogers; Ravinder J Singh; Jennifer E Van Eyk; Steven H Wong; Shucha Zhang; Daniel W Chan; Xian Chen; Matthew J Ellis; Daniel C Liebler; Karin D Rodland; Henry Rodriguez; Richard D Smith; Zhen Zhang; Hui Zhang; Amanda G Paulovich
Journal:  Clin Chem       Date:  2016-01       Impact factor: 8.327

4.  Immobilized Metal Affinity Chromatography Coupled to Multiple Reaction Monitoring Enables Reproducible Quantification of Phospho-signaling.

Authors:  Jacob J Kennedy; Ping Yan; Lei Zhao; Richard G Ivey; Uliana J Voytovich; Heather D Moore; Chenwei Lin; Era L Pogosova-Agadjanyan; Derek L Stirewalt; Kerryn W Reding; Jeffrey R Whiteaker; Amanda G Paulovich
Journal:  Mol Cell Proteomics       Date:  2015-11-30       Impact factor: 5.911

Review 5.  Emerging proteomic technologies for elucidating context-dependent cellular signaling events: A big challenge of tiny proportions.

Authors:  Sarah J Parker; Koen Raedschelders; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2015-02-10       Impact factor: 3.984

Review 6.  Clinical potential of mass spectrometry-based proteogenomics.

Authors:  Bing Zhang; Jeffrey R Whiteaker; Andrew N Hoofnagle; Geoffrey S Baird; Karin D Rodland; Amanda G Paulovich
Journal:  Nat Rev Clin Oncol       Date:  2019-04       Impact factor: 66.675

Review 7.  Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.

Authors:  Nathan P Manes; Aleksandra Nita-Lazar
Journal:  J Proteomics       Date:  2018-02-13       Impact factor: 4.044

Review 8.  Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.

Authors:  Sophie Paczesny; Christine Duncan; David Jacobsohn; Robert Krance; Kathryn Leung; Paul Carpenter; Catherine Bollard; Jamie Renbarger; Kenneth Cooke
Journal:  Proteomics Clin Appl       Date:  2014-10-30       Impact factor: 3.494

9.  Antibody-based detection of protein phosphorylation status to track the efficacy of novel therapies using nanogram protein quantities from stem cells and cell lines.

Authors:  Mark Aspinall-O'Dea; Andrew Pierce; Francesca Pellicano; Andrew J Williamson; Mary T Scott; Michael J Walker; Tessa L Holyoake; Anthony D Whetton
Journal:  Nat Protoc       Date:  2014-12-18       Impact factor: 13.491

10.  Evaluation of Multi-tRNA Synthetase Complex by Multiple Reaction Monitoring Mass Spectrometry Coupled with Size Exclusion Chromatography.

Authors:  Seong-Jun Park; Hee-Sung Ahn; Jun Seok Kim; Cheolju Lee
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.